Thomas Hovasse

Showing 1-6 of 6 articles

Author Antoine Filipovic-Pierucci

Polymer-free drug-coated coronary stents are cost-effective in patients at high bleeding risk: economic evaluation of the LEADERS FREE trial

Filipovic-Pierucci A, Durand-Zaleski I, Butel T, Greene S, Hovasse T, Iniguez A, Nazzaro M, Oldroyd K, Talwar S, Richardt G, Windhovel U, Urban P, Morice M

February 20, 2018 | 10.4244/EIJ-D-17-00286

Author Francesca Sanguineti

Coronary interventions

Chronic total coronary occlusion treated by percutaneous coronary intervention: long-term outcome in patients with and without diabetes

Sanguineti F, Garot P, O’Connor S, Watanabe Y, Spaziano M, Lefèvre T, Hovasse T, Benamer H, Unterseeh T, Chevalier B, Morice M, Louvard Y

February 3, 2017 | 10.4244/EIJ-D-15-00278

Author Jean Fajadet

Coronary interventions

Twelve-month results of a prospective, multicentre trial to assess the everolimus-eluting coronary stent system (PROMUS Element): the PLATINUM PLUS all-comers randomised trial

Fajadet J, Neumann F-J, Hildick-Smith D, Petronio A, Zaman A, Spence M, Wöhrle J, Elhadad S, Roberts D, Hovasse T, Valdes M, Silber S

January 20, 2017 | 10.4244/EIJV12I13A262

Author Andrejs Erglis

Interventions for valvular disease

The Arto transcatheter mitral valve repair system

Erglis A, Thomas M, Morice M, Narbute I, Zabunova M, Hovasse T, Poupineau M, Rudzitis A, Kamzola G, Zvaigzne L, Greene S, Rogers J

September 17, 2015 | 10.4244/EIJV11SWA12

Author Kentaro Hayashida

Impact of CT-guided valve sizing on post-procedural aortic regurgitation in transcatheter aortic valve implantation

Hayashida K, Bouvier E, Lefèvre T, Hovasse T, Morice M, Chevalier B, Romano M, Garot P, Mylotte D, Farge A, Donzeau-Gouge P, Cormier B

September 28, 2012 | 10.4244/EIJV8I5A85

Author Darren Mylotte

Non-compliant balloons for final kissing inflation in coronary bifurcation lesions treated with provisional side branch stenting: a pilot study

Mylotte D, Hovasse T, Ziani A, Lefèvre T, Dumonteil N, Louvard Y, Carrié D

February 21, 2012 | 10.4244/EIJV7I10A187

1

Latest news

Antiplatelet strategies for complex PCI, are all DES equal at 10-year follow-up? cost-effectiveness of TAVR…find all the answers in the new issue

(Intravascular lithotripsy (3.5 mm Shockwave; left), followed by balloon dilatation (4.0 mm NC; right))

December 6, 2019

The challenge of innovation for the (interventional?) cardiology world

December 6, 2019

New this week: A Dose-response Meta Analysis, stroke after MitraClip and more

December 10, 2019

New update! Discover 17 new trials

(The Trials book is supported by Biotronik)

October 29, 2019

Guidance Papers

Guidelines, consensus & position papers

2019 – A leap year for valvular heart disease

(Course directors PCR London Valves 2019)

November 15, 2019

Last week's JAA's: EXTREME Study, Stent Optimization and more

December 3, 2019

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke